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Abstract
Anemia is a common disorder, characterized by abnormally low levels of red blood cells or
hemoglobin. The mechanisms of anemia development and response have been thoroughly
studied in mammals, but little is known in other vertebrates, particularly teleost fish. In this
study, different degrees of anemia were induced in healthy European sea bass specimens
(Dicentrarchus labrax) and at pre-determined time points hematological parameters, liver
iron content and the expression of genes involved in iron homeostasis and hematopoiesis,
with particular attention on hepcidins, were evaluated. The experimental anemia prompted
a decrease in hamp1 expression in all tested organs, in accordance to an increased need
for iron absorption and mobilization, with slight increases in hamp2 in the kidney and intes-
tine. The liver was clearly the major organ involved in iron homeostasis, decreasing its iron
content and showing a gene expression profile consistent with an increased iron release
and mobilization. Although both the spleen and head kidney are involved in erythropoiesis,
the spleen was found to assume a more preponderant role in the recovery of erythrocyte
levels. The intestine was also involved in the response to anemia, through the increase of
iron transporting genes. Administration of Hamp1 or Hamp2 mature peptides showed that
only Hamp1 affects hematological parameters and liver iron content. In conclusion, the
molecular mechanisms of response to anemia present in sea bass are similar to the ones
described for mammals, with these results indicating that the two hepcidin types from tele-
osts assume different roles during anemia.
Introduction
Anemia is one of the most common disorders of the blood, resulting from an abnormally low
level of red blood cells or hemoglobin. Anemia symptoms can range from asymptomatic to
weakness, shortness of breath, fatigue, and in the most severe cases, organ damage and heart
failure, leading to death. Although numerous types of anemia have been characterized, they
can be divided into three major groups: caused by blood loss, by excessive hemolysis or by
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impaired erythropoiesis. There are several causes that can lead to the development of anemia,
but the most common is iron deficiency [1]. Iron is essential for the synthesis of hemoglobin,
the key component of red blood cells responsible for oxygen binding and transport [2, 3], as
well as numerous other cellular processes [4–8]. Iron deficiency is usually derived from insuffi-
cient iron uptake (low dietary iron), deficiencies in iron absorption, storage or transport, or sig-
nificant blood loss. When anemia is established, one of the results is a decrease in the levels of
oxygen that the blood is able to carry, which can eventually lead to hypoxia. In hypoxia, less
oxygen is available for normal cellular processes, leading to decreased energy production, com-
promised cell proliferation and repair, reduced muscular activity and, in extreme cases, severe
oxygen deprivation to the brain, which could lead to death.
As such, it is clear that there is a tight interconnection between red blood cell levels, oxygen
homeostasis and iron metabolism. The existing studies addressing the mechanisms involved in
the establishment of anemia and the genes involved in hematopoiesis are mostly focused on
mammals and there are still numerous gaps in the understanding of these processes in lower
vertebrates, particularly fish. With the continuous depletion of the natural fish stocks, many
believe that in the years to come aquaculture will represent one of the major food sources. Con-
sequently, a better understanding of the mechanisms of iron metabolism in response to anemia
and to the need for an enhanced erythropoiesis is crucial for the increased welfare of aquacul-
ture species.
Assuming a central role in iron metabolism is hepcidin, a small cysteine-rich peptide that is
considered to be the key regulator of iron metabolism [9–12]. Hepcidin is mostly produced in
the liver hepatocytes, but it has also been described in other cell types and tissues. As an iron
metabolism regulator, hepcidin synthesis is regulated by several stimuli through a myriad of
pathways (reviewed in [13, 14]), being induced by elevated iron levels and infection/inflamma-
tion and decreased by low iron levels, anemia and hypoxia. When iron stores are adequate or
high, or during infection, hepcidin binds to the iron exporter ferroportin, causing its internali-
zation and degradation, thus blocking the release of iron from macrophages, hepatocytes and
enterocytes, and in the later, also leading to decreased iron absorption [15, 16]. Inflammation
also leads to a limitation in iron availability not only for pathogens but also for normal erythro-
poiesis, which could lead to the so called anemia of inflammation [17, 18]. On the other hand,
when iron or oxygen levels are low, hepcidin production is attenuated or suppressed, increasing
cellular iron efflux and consequently intestinal uptake.
An interesting fact about fish hepcidins is that, contrary to mammals, where a single gene
exists (with the mouse being the sole known exception [19]) and performs both as an antimi-
crobial peptide and iron regulator, many teleost fish present two types of hepcidin (commonly
referred to as hamp1 and hamp2) [20–24] and although the full extent of their roles remains
unclear, one is usually more associated with iron metabolism regulation and the other with the
antimicrobial response.
With the present work, we intend to clarify the molecular mechanisms of response to ane-
mia in a commercially relevant teleost fish, the European sea bass (Dicentrarchus labrax), by
investigating the expression of several genes known to be involved in iron homeostasis and
hematopoiesis, with a particular focus in understanding the roles of the different hepcidin
genes.
Materials and Methods
Animals
European sea bass (Dicentrarchus labrax), with an average weight of 50g, were provided by a
commercial fish farm in the south of Portugal (Piscicultura do Vale da Lama, Lagos, Portugal).
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Fish were kept in 500 liters recirculating sea water tanks at 21±1°C, with a 12-hour light/dark
cycle and fed daily to satiation. Before each treatment, fish were anaesthetized with ethylene
glycol monophenyl ether (2-phenoxyethanol, 0.3 ml/liter, Merck, Algés, Portugal). All animal
experiments were carried out in strict compliance with national and international animal use
ethics guidelines, approved by the animal welfare and ethic committee of the Instituto de Biolo-
gia Molecular e Celular (IBMC), with permit ref. Ofício Circular n° 99, 0420/000/000 of 09/11/
2009 from the Direcção Geral de Alimentação e Veterinária (DGAV), Portuguese Ministry of
Agriculture and Sea, and conducted by FELASA Category C/DGAV certified investigators.
Experimental anemias
Fish were individually weighted and bled from the caudal vessels the equivalent v/w of either
1% (“light” anemia) or 2.5% (“severe” anemia) body mass. Control fish were subjected to the
same manipulation (anesthesia, weighting, pinching) but no blood was removed. One, four,
seven and fourteen days after treatment, four fish from each of the experimental groups were
anaesthetized and blood was drawn from the caudal vessels for evaluation of hematological
parameters. Subsequently, fish were euthanized with an overdose of anesthetic, dissected and
major tissues involved in iron homeostasis and hematopoiesis (liver, spleen, head kidney and
intestine) were collected, snap frozen in liquid nitrogen and stored at -80°C until further use.
Hematological parameters and liver iron content
To determine the impact of the experimental bleeding on the hematological parameters,
peripheral blood was drawn from the caudal vessels at each experimental time point in termi-
nally sampled animals. For red blood cell counts and hematocrit determination, 150 μl samples
of blood were used in 1:1 dilutions with heparin in PBS (1000 units/ml). For determination of
serum parameters, non-heparinized blood was transferred into 1.5 ml microcentrifuge tubes,
and allowed to clot for 8 h at 4°C. The samples were centrifuged twice at 16000×g until a clear
serum was obtained. Serum iron and transferrin saturation were determined by the Liquid Fer-
rozine1method (Thermo Electron, Victoria, Australia) according to the manufacturer’s
specifications.
Non-heme iron was measured in livers by the bathophenanthroline method [25]. Briefly,
liver samples with an average weight of 100 mg were placed in iron-free Teflon vessels
(ACV-Advanced Composite Vessel, CEM Corporation, Matthews NC, USA) and dried in a
microwave oven (MDS 2000, CEM Corporation). Subsequently, dry tissue weights were deter-
mined and samples digested in an acid mixture (30% hydrochloric acid and 10% trichloroacetic
acid) for 20 h at 65°C. After digestion, a chromogen reagent (5 volumes of deionised water, 5
volumes of saturated sodium acetate and 1 volume of 0.1% bathophenanthroline sulfonate/1%
thioglycollic acid) was added to the samples in order to react with iron and obtain a colored
product that was measured spectrophotometrically at 535 nm. The extinction coefficient for
bathophenanthroline is 22.14 mM-1cm-1.
RNA isolation and cDNA synthesis
Total RNA was isolated from liver, spleen, head kidney and posterior intestine with the Pure-
Link RNAMini Kit protocol for animal tissues (Invitrogen, Life Technologies) with the
optional on-column PureLink DNase treatment (Invitrogen), according to the manufacturer’s
instructions. Total RNA quantification was performed using a NanoDrop 1000 spectropho-
tometer (Thermo Scientific, WalthamMA, USA) and quality was assessed by running the sam-
ples in an Experion Automated Electrophoresis Station (Bio-Rad). For all samples, 1.25 μg of
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each were converted to cDNA by Thermoscript™ and an oligo (dT) 20 primer (Invitrogen), for
40 min at 50°C, according to the manufacturer’s protocol.
Analysis of gene expression by quantitative RT-PCR
Relative levels of several genes mRNAs were quantified in relevant organs of untreated, control
and anemic fish, by real-time PCR. Genes analyzed include genes involved in iron homeostasis
and regulation (hamp1, hamp2, tmprss6, hjv, bmp6, bmpr2, smad4, smad1/5/8, tfr1 and tfr2),
hematopoiesis (epo, epor, hgb and gata2), hypoxia (hif1a), iron uptake (slc11a2a and slc11a2b),
iron storage (fth), iron export (fpn) and iron transport (tf). One μl of each cDNA sample was
added to a reaction mix containing 10 μl iQ SYBR Green Supermix (Bio-Rad), 8.5 μl of ddH20
and 250 nM of each primer (Table 1), making a total volume of 20 μl per reaction. A non-tem-
plate control was included for each set of primers. The cycling profile was as follows: 94°C for
3.5 min, 40 cycles of 94°C for 30 s, 59°C for 30 s and 72°C for 30 s. Samples were prepared in
duplicates, a melting curve was generated for every PCR product to confirm the specificity of
the assays and a dilution series was prepared to check the efficiency of the reactions. β-actin
was used as the housekeeping gene. The comparative CT method (2-ΔΔCT method) based on
cycle threshold (CT) values was used to analyze gene expression levels.
Peptide administration
To evaluate the biological effects of sea bass hepcidin on the hematological parameters and
liver iron content, synthetic peptides coding for the predicted mature peptides of Hamp1 (QS
HLSLCRWCCNCCRGNKGCGFCCKF), Hamp2.1 (HSSPGGCRFCCNCCPNMSGCGVCC
TF), and Hamp2.2 (HSSPGGCRFCCNCCPNMSGCGVCCRF) were commercially produced
Table 1. Primers used for gene expression analysis.
Forward (5'!3') Reverse (5'!3')
actb CAGAAGGACAGCTACGT GTCATCTTCTCCCTGTTGGC
hamp1 CATTGCAGTTGCAGTGACACT CAGCCCTTGTTGCCTCTG
hamp2 CTGCTGTCCCAGTCACTGA ACCACATCCGCTCATATTAGG
bmp6 AAGCAGCCTTTCATGGTGGC GGTTCATCAGGTGCACCAG
bmpr2 GCTGTAGCAGCCTTCTTTGG CTCCTTTGAAGAGCTCGGTGT
epo AGGCCAATCTGTGACCTGAG GCAGTGCTGTGTTGGTGACT
epor GCCTATGTCACCCTCAATGC GAGTCTGCCACTGCCATGTA
fpn GGCCTACTACAACCAGAACAT AGGCCGCACTTCTTGCGAA
fth AACCATGAGTTCTCAGGTGAG TTAGCTGCTCTCTTTGCCCAG
gata2 CCCTGACCATGAAGAAGGAAG TAGGCAGCATGTGTCCAGAG
hgb CCAGGCTTTGACCAGACTTC TGGACATCAGGGGTGAACTG
hif1a AGCGGAGGAAGGAGAAGTC CCATGAGAAAACCCTCCAGAG
hjv AGGGCATCGAGGACCTGCT CGCTCACCACCGAGCCAT
slc11a2a CGCGTTCAACCTCCTCTCCTCT AGCCCTCGCAGTACGGCACA
slc11a2b TGCTCTCAACCTTCTCTCTGTG AGCCGGCGCAGTAAGGTAAG
smad4 CAGTGCCACAGACAGATGCA TGTGCAGGACCTCGTCCAG
smad1/5/8 CCATCGTCTACTACGAACTCAAC GTGACGTCCTGTCGGTGATA
tf CAACAGTATGGGTGCTGACG ACTGGCAGAGCACTTGGACT
tfr1 CTCCTTCAACCACACCCAGT GACCAGTACCGAGGTTCCAA
tfr2 GCCTACTTCAGTCTGGACCA CCTCTGGACTGCAGCTCTG
tmprss6 CGCACTAATCTCCAGCCAGT ATTCTGGGAGTGACCAGGTG
doi:10.1371/journal.pone.0153940.t001
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in the oxidized, folded form (with disulfide bonds) (Bachem AG, Bubendorf, Switzerland) [22]
and administered to healthy sea bass. Briefly, peptides were diluted in 1× PBS to a final concen-
tration of 100 μM and each fish was i.p. injected with 100 μl. Control animals received a similar
volume of saline. At 1, 4, 7, 10 and 14 d post peptide administration, four fish from each group
were anesthetized, blood was drawn from the caudal vessels for evaluation of hematological
parameters and liver collected for liver iron determination, as previously described.
Statistical analysis
Statistical analysis was carried out using GraphPad Prism 5 (GraphPad Software, Inc). Data
normality was checked by performing Kolmogorof-Smirnoff test and Student’s T-test was used
for estimating statistical significance. Multiple comparisons were performed with Two-way
ANOVA and post hoc Tukey test. A p value of less than 0.05 was considered statistically
significant.
Results
Hematological parameters and liver iron
Hematological parameters and liver iron content were measured to validate and follow the pro-
gression of the experimental models of anemia (Fig 1). Similar significant decreases were
observed in red blood cell numbers, hematocrit, serum iron and transferrin saturation in both
light and severe anemia groups, although all parameters were consistently lower in the severe
anemia group. Liver iron content was significantly reduced in the severe anemia group 1 day
after anemia induction, whereas no significant variations were observed for the light anemia
group.
Gene constitutive expression
Constitutive expression of several genes was evaluated in relevant organs involved in iron
homeostasis and hematopoiesis, including the liver, spleen, head kidney and posterior intes-
tine. Overall, most genes presented the highest expression in the liver, with some exceptions
(Table 2), with noticeable genes being hamp1, hamp2, fth, tf, slc11a2b and tmprss6. Also of rele-
vance are the high levels of epor, hgb and tfr1 in the head kidney, and of slc11a2a in the poste-
rior intestine.
Fig 1. Hematological parameters and liver iron content.Results are presented as mean ± SD (n = 4).
Differences were considered significant between control and treated groups as a, p<0.05; b, p<0.01; c,
p<0.001; and between treated groups as d, p<0.05; e, p<0.01; f, p<0.001.
doi:10.1371/journal.pone.0153940.g001
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Gene expression under experimental conditions
Hamp1 and hamp2 expression in the liver, spleen, head kidney and posterior intes-
tine. Similar patterns of expression were observed in the liver, spleen, head kidney and intes-
tine for both experimental anemias (Fig 2). In the liver, hamp1 expression was found to be
significantly decreased throughout the whole experiment, with minimum levels reached as
soon as day 1 and a gradual recovery towards day 14. In turn, hamp2 was only significantly
decreased at day 4 in the severe anemia group. In the spleen, no significant variations were
observed in hamp1 expression up to day 7, when an abrupt decrease occurred, followed by a
slight recovery towards day 14. No changes were observed for hamp2. In the head kidney,
hamp1 expression dropped significantly at day 1 and gradually recovered up to day 14. Hamp2
on the other hand, was increased at day 4 in the severe anemia group, returning to normal lev-
els at day 7. Although not significant, the same tendency was observed for the light anemia
group. In the intestine, a decrease in hamp1 was observed as soon as day 1 way for the severe
anemia group, and only at day 4 in the light anemia group, with both gradually recovering
towards day 14.Hamp2 expression was increased at day 4 in the severe anemia group, kept at
still higher than normal levels at day 7 and returned to normal levels at day 14.
Gene expression in the liver. In the liver, we evaluated the expression of genes involved in
hepcidin regulation, iron mobilization, hypoxia sensing and hematopoiesis/erythropoiesis-
related factors. Overall, the severe anemia elicited a much more intense response in gene
expression changes (Fig 3). Several genes associated with the iron-sensing pathways of hepcidin
regulation were found to be down-regulated in the severe anemia group, such as bmp6 and its
receptor bmpr2 and co-receptor hjv, and also the signaling molecules smad4 and smad1/5/8.
The only gene found to be upregulated was tmprss6, at day 4. In the light anemia group, the
Table 2. Constitutive expression of several iron-related genes in sea bass liver, spleen, head kidney and posterior intestine, measured by real-
time PCR. Each sample was normalized to beta actin, calculated by the comparative CT method (2-ΔΔCT). Values are presented as means (n = 4). N.D.–not
detected.
Liver Spleen Head Kidney Posterior Intestine
hamp1 1,000,000 15,000 13,500 24,000
hamp2 200,000 20,000 2,500 12,000
bmp6 33,000 3,000 700 9000
bmpr2 25,000 900 900 1,400
epo 900 560 40 110
epor 8,100 22,000 46,000 1,700
fpn 8,800 8,500 3,800 9,200
fth 7,830,000 460,000 1,100,000 1,470,000
gata2 3,300 11,000 7,000 9,600
hgb 460,000 1,000,000 11,500,000 75,000
hif1a 160 50 40 70
hjv 19,300 1 N.D. 2
slc11a2a 2,200 260 290 10,000
slc11a2b 150,000 300 250 2,900
smad4 5,200 600 200 140
smad5 2,800 200 250 500
tf 9,000,000 10 1 6
tfr1 80,000 4,500 36,000 7,300
tfr2 6,500 90 50 260
tmprss6 900,000 400 200 30
doi:10.1371/journal.pone.0153940.t002
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Fig 2. Hamp1 and hamp2mRNA expression.Measured in in the liver, spleen, head kidney and posterior
intestine by real-time PCR, after 1, 4, 7 and 14 of experimental anemias. Results are presented as
mean ± SD (n = 4). Differences were considered significant between control and treated groups as a, p<0.05;
b, p<0.01; c, p<0.001.
doi:10.1371/journal.pone.0153940.g002
Hepcidin and Anemia in Teleosts
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only changes observed were a decrease in smad4 expression at day 4. When looking at genes
involved in iron mobilization, we observed a decrease in fth expression in the severe anemia
group. Significant up-regulations were observed for the iron transporter tf, as well as its recep-
tors, tfr1 and tfr2, and also of the iron exporter fpn, for both anemia levels. Finally, when look-
ing at hematopoiesis-related factors, there was a significant increase in epo expression in both
groups, although at different time points. A significant increase was also observed for hif1a at
day 4 for both anemias, whereas for gata2 a significant decrease was observed at days 7 and 14
in the severe anemia group and day 14 in the light anemia group.
Gene expression in the spleen. Expression studies in the spleen were focused on genes
involved in hematopoiesis (Fig 4). Similar responses were observed in response to both experi-
mental anemias, although overall more pronounced in the severe anemia group. Expression
increases were observed at days 4 and 7 for epo, epor and hgb, at day 1 for tfr1 and day 14 for
tfr2. Gata2 was the only gene found to be down-regulated, reaching minimal levels at day 7
and with a gradual recovery towards day 14.
Gene expression in the head kidney. Expression studies in the head kidney were also
focused on genes involved in hematopoiesis (Fig 5). Expression levels of epo were found to be
Fig 3. Gene expression in the liver, after 1, 4, 7 and 14 days of experimental anemias.Genes analyzed
include genes encoding for hematopoietic transcription factors (gata2) and erythropoiesis-related factors
(epo/epor), from the two major pathways of iron-sensing (tmprss6/hjv/bmp6/bmpr2/smad and tf/tfr1/tfr2), for
response to hypoxia (hif1a), iron storage (fth) and iron export (fpn). Values are presented as mean ± SD
(n = 4). Differences were considered significant between control and treated groups as a, p<0.05; b, p<0.01;
c, p<0.001; and between treated groups as d, p<0.05; e, p<0.01; f, p<0.001.
doi:10.1371/journal.pone.0153940.g003
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increased at days 4 and 7 in the severe anemia group, and day 7 in the light anemia group. How-
ever, variations in the expression of its receptor (epor) were only observed in the severe anemia
group, presenting increased expression also at days 4 and 7.Gata2 levels were found to be simi-
larly decreased at days 1 and 4 in both groups, but while levels recovered to normal values in the
light anemia group at day 7, they were kept down-regulated in the severe anemia group until the
end of the experiment. Variations in the expression of transferrin receptors were only observed
for the severe anemia group, with an up-regulation of tfr1 at day 14 and tfr2 at day 4.
Gene expression in the posterior intestine. In the posterior intestine (Fig 6), expression
levels of genes commonly associated with iron uptake (slc11a2a/b), export (fpn) and storage
(fth) in the enterocytes were measured, as well as of a possible intestine-secreted regulator of
liver hepcidin (bmp6). A significant increase of slc11a2a expression was observed in the severe
anemia group, starting at day 4 and kept up-regulated until day 14. An increase was also
observed at day 7 in the light anemia group. No significant changes where observed for
slc11a2b in either group. In the severe anemia group, a down-regulation of bmp6 and fth was
also observed, at days 14 and 7, respectively. A similar pattern of fpn expression was observed
for both groups, with an up-regulation starting at day 1, reaching the peak at day 4 and gradu-
ally dropping to control levels towards day 14.
Fig 4. Gene expression in the spleen, after 1, 4, 7 and 14 days of experimental anemias.Genes
analyzed include genes encoding hematopoietic transcription factors (gata2) and erythropoiesis-related
factors (epo/epor/hg), and involved in iron homeostasis (tfr1 and tfr2). Values are presented as mean ± SD
(n = 4). Differences were considered significant between control and treated groups as a, p<0.05; b, p<0.01;
c, p<0.001; and between treated groups as d, p<0.05; e, p<0.01; f, p<0.001.
doi:10.1371/journal.pone.0153940.g004
Fig 5. Gene expression in the head kidney, after 1, 4, 7 and 14 days of experimental anemias.Genes
analyzed include genes encoding hematopoietic transcription factors (gata2) and erythropoiesis-related
factors (epo/epor/hg), and involved in iron homeostasis (tfr1 and tfr2). Values are presented as mean ± SD
(n = 4). Differences were considered significant between control and treated groups as a, p<0.05; b, p<0.01;
c, p<0.001; and between treated groups as d, p<0.05; e, p<0.01; f, p<0.001.
doi:10.1371/journal.pone.0153940.g005
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Hematological parameters and liver iron after peptide administration
Hematological parameters and liver iron content were measured to evaluate the effects of
administration of sea bass Hamp1 and Hamp2 mature peptides (Fig 7). Administration of
Hamp1 led to steady declines of all measured hematological parameters, including red blood
cell numbers, hematocrit, serum iron and transferrin saturation. On the other hand, liver iron
content steadily increased during the course of the experiment. Administration of either
Hamp2 failed to produce any significant effects on the hematological parameters or liver iron
content, with all parameters kept similar to control levels.
Discussion
Anemia is a very common disorder, which is characterized by abnormally low numbers of
erythrocytes or hemoglobin in the blood. Iron deficiency is one of the most frequent causes for
anemia, since iron is an essential element for the synthesis of hemoglobin, a crucial molecule
present in the red blood cells. The causes, development and effects of iron deficiency anemia
Fig 6. Gene expression in the intestine, after 1, 4, 7 and 14 days of experimental anemias.Genes
analyzed include genes encoding transmembrane divalent metal transporters (slc11a2a/b), a possible
intestine-secreted hepcidin regulator (bmp6), for iron storage (fth) and iron export (fpn). Values are presented
as mean ± SD (n = 4). Differences were considered significant between control and treated groups as a,
p<0.05; b, p<0.01; c, p<0.001; and between treated groups as d, p<0.05; e, p<0.01; f, p<0.001.
doi:10.1371/journal.pone.0153940.g006
Fig 7. Hematological parameters and liver iron content after peptide administration. Sea bass Hamp1
and two different Hamp2 mature peptides were administered to healthy fish and hematological parameters
and liver iron content were evaluated 1, 4, 7, 10 and 14 days after administration. Results are presented as
mean ± SD (n = 4). Differences were considered significant between control and treated groups as a, p<0.05;
b, p<0.01; c, p<0.001; between Hamp1 and Hamp2.1 as d, p<0.05; e, p<0.01; f, p<0.001; and between
Hamp1 and Hamp2.2 as g, p<0.05; h, p<0.01; i, p<0.001. No significant differences were observed between
both Hamp2 groups.
doi:10.1371/journal.pone.0153940.g007
Hepcidin and Anemia in Teleosts
PLOS ONE | DOI:10.1371/journal.pone.0153940 April 21, 2016 10 / 17
continue to be the focus of much attention in humans and other mammalian models, but have
deserved little attention in other vertebrates, particularly economically important species such
as teleost fish.
To better understand the molecular mechanisms of response to anemia in teleost fish, we
focused our attention on the study of several genes that in mammals are known to be impli-
cated in iron homeostasis, erythropoiesis, hematopoiesis and response to hypoxia. For that, we
created two experimental models of anemia, where we induced either “light” or “severe” ane-
mia conditions, through bleeding. To validate our experimental models, we monitored several
hematological parameters as well as iron content in the liver, being the major organ of iron
storage. As expected, a decrease in all measured hematological parameters was observed, clearly
more accentuated in the severe anemia group. Furthermore, the severe anemia also induced a
significant decrease in liver iron content, indicating an urgent need of iron mobilization to
replenish the lost red blood cells. With our models thus validated, we proceeded to analyze the
expression of several genes, in relevant organs known to be involved in iron homeostatis and
hematopoiesis in fish, such as the liver, spleen, head kidney and posterior intestine.
One of the central players in all this is hepcidin (hamp), a small cysteine rich antimicrobial
peptide considered to be the key regulator of systemic iron homeostasis [11, 12]. Unlike other
vertebrates, where a single hepcidin gene seems to be the norm (with the exception of the
mouse), many teleost fish, including sea bass, appear to have two hepcidin homologues, hamp1
and hamp2 [22, 26].Hamp1 has been found as a single copy gene in all studied fish species and
is orthologous to the hepcidin mammalian gene, whereas hamp2 seems to be exclusive to
acanthopterygians, often presenting multiple copies. Although not always clear, several studies
suggest that hamp1 has a role focused on iron metabolism regulation, whereas the various
hamp2 have a mostly antimicrobial role [20–24, 27]. Looking into hamp1, we observed a
decrease in expression in all tested tissues, for both anemia levels. The decreased expression in
the liver is in line with our previous observations for sea bass [28], as well as with what is
observed in channel catfish [29] and also mammalian models [30]. Information on the effects
of anemia on hepcidin expression in the spleen, head kidney and intestine is rather scarce.
However, it has been shown that these organs respond to variations in iron levels, more specifi-
cally, by increasing hepcidin expression in response to iron overload [21, 24, 31]. As such, it is
logical to think that they will respond in a mirror fashion to iron deficiency, by decreasing hep-
cidin expression, which is what we observe in sea bass. Overall, these decreases in hamp1
expression present a higher relevance in the liver, as the major organ of not only hepcidin con-
stitutive expression, but also of several other genes involved in its regulation. As with mam-
mals, it is likely that spleen, head kidney and intestine produced hamp1 has a low impact on a
systemic level and is only involved in the control of local iron fluxes.
Expression of the other sea bass homolog, hamp2, is also decreased in the liver, and as such
we cannot discard some sort of involvement in iron homeostasis, when conditions are dire
(such as during severe anemia). However, hamp2 expression increases in both head kidney and
intestine. Considering the mostly antimicrobial role of hamp2 [22], this increase remains puz-
zling because: 1) there is no inflammatory stimuli; 2) there are no variations in the expression
of genes of the inflammatory pathway (IL6/JAK/STAT pathway–data not shown); and 3) a
possible crosstalk with the iron sensing pathways seems to be out of the question, as they are
both down-regulated, which would lead to a decrease in hepcidin expression (as for hamp1).
One possible explanation could be the influence of other pathways of regulation not analyzed
in this study, either known ones or teleost fish specific, which certainly deserves further investi-
gation. Another possibility is that a preventive increase in hamp2 levels may be beneficial, since
a prolonged state of anemia is bound to introduce a potential debilitative state in fish, making
them more susceptible to pathogens.
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In the liver, decreases in hepcidin expression were similarly accompanied by changes in the
expression of genes of the regulatory pathways commonly associated with iron status, namely
the HJV/BMP/SMAD and TfR mediated pathways [14]. The bone morphogenetic protein 6
(BMP6) has been recently identified as a key endogenous regulator of hepcidin and iron metab-
olism in mammals [32, 33]. Together with membrane-bound hemojuvelin (mHJV), it binds to
the BMP receptor in the hepatocytes, leading to an up-regulation of hepcidin. However, the
exact cellular source of BMP6 is still surrounded by controversy, with a group of authors claim-
ing that the predominant source for BMP6 are the epithelial cells of the small intestine [34],
whereas other authors propose that there is no role for the intestine and the liver is the key site
of BMP6 production [35]. In sea bass, the liver would be not only be one of the major sites of
bmp6 production, as evidenced by its observed decrease, but also of bmp6-mediated regulation,
since there were significant decreases in the expression of its receptor (bmpr2) and co-receptor
(hjv), as well as an increase in tmprss6 expression, a known cleaver of membrane-bound hemo-
juvelin [36]. Looking downstream in this regulatory pathway, decreases in the expression of
the signaling molecules smad4 and smad1/5/8 further reinforce the idea of an attenuation of
this whole regulatory pathway.
When taking a closer look to the transferrin receptor mediated pathway, the immediate con-
cern would be the apparent lack of hfe in teleost fish, which could compromise the functioning
of this pathway. However, we have previously shown that despite the lack of hfe, the TfR-medi-
ated pathway still responds not only to changes in the iron status, but also to inflammatory sti-
muli [28]. In these experiments, we observed increases in the expression of both transferrin
receptors, in accordance with what is observed for mammals during iron deficiency anemia,
where synthesis of the receptor is upregulated, leading to higher circulating levels of a soluble
form [37, 38]. Soluble TfR (sTfR), together with serum ferritin levels, reflects different stages of
iron deficiency. In the early onset of iron deficiency, there is a decline in serum ferritin, but
when iron stores start to become depleted, sTfR levels begin to rise, reflecting tissue iron defi-
ciency and iron-deficient erythropoiesis.
In line with the decrease in liver iron levels, a downregulation in the expression of the iron
storage molecule fth and upregulation in the iron transporter tf and iron exporter fpn further
suggest a decrease in storage and an increase in release and mobilization towards the organs
involved in hematopoiesis.
When analyzing genes involved in erythropoiesis, we observed a very significant increase in
erythropoietin (epo) expression. We present two possible interpretations for this data. On one
hand, liver produced erythropoietin might be exerting an inhibitory effect on liver hepcidin
expression. It has been proposed that erythropoietin can directly repress hepcidin in hepato-
cytes through EPOR-mediated regulation of the transcription factor C/EBPα [39], or indirectly
through the suppression of SMAD4 and STAT3 signaling [40]. Another possibility is that this
liver produced erythropoietin might be contributing to stimulate an increase in hemoglobin
production in the hematopoietic organs, such as the spleen or the head kidney. Expression of
the erythropoiesis factor hif1a seems to be in line with the increased epo expression. Oxygen
deprivation is often associated with anemia, which in turn leads to an increased expression of
oxygen sensitive transcriptional factors, such as hif1a. It can then bind to the hypoxia response
elements present in the epo and hamp genes, enhancing or repressing their expressions, respec-
tively [41]. Conversely, expression of the hematopoiesis transcription factor gata2, which is
known to negatively regulate erythropoietin [42, 43], was found to be decreased.
We also looked into gene expression in the hematopoietic organs, the spleen and the head
kidney. In mammals, erythropoiesis occurs in the bone marrow and is mainly regulated by the
hormone erythropoietin (EPO). In teleost fish, on the other hand, the head kidney and the
spleen are considered to be the major erythropoietic organs, although each organ seems to
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present a different importance in different fish species [37]. For sea bass, there is some evidence
of the head kidney’s involvement in erythropoiesis and thrombopoiesis [44], but information
on the possible involvement of the spleen is scarce. Our gene expression studies point towards
the involvement of both spleen and head kidney in erythrocyte production, with the spleen
seemingly assuming a more preponderant role. Similar increases in epo levels are observed in
both organs, as well as of its receptor, epor, but constitutive levels of epo in the spleen are higher
than the head kidney (14:1) and as such, the increased expression in the spleen is overall much
higher. Conversely, expression levels of gata2 are decreased, which likely results in a reduced
repression of epo. But what really gives strength to the idea that the spleen may have a more
important role in erythropoiesis in sea bass are the changes in hemoglobin and transferrin
receptors expression. Although constitutive levels of hg are higher in the head kidney (~11:1),
the biggest increase in expression occurs in the spleen, becoming millions of times higher than
in the head kidney. This is accompanied by an earlier increase of tfr1 in the spleen, against a
later increase observed in the head kidney, and vice-versa for tfr2. TfR1 is ubiquitously
expressed, with greater relevance in erythroid cells, being deeply involved in the control of cel-
lular iron uptake, and is essential for the development of erythrocytes [31]. On the other hand,
TfR2 is mainly expressed in the liver and to a much lesser extent in erythroid cells, with a
smaller contribution to cellular iron uptake and a not yet clearly defined role in the regulation
of iron homeostasis [45]. Furthermore, although it is expressed at the mRNA level in erythroid
cells, it does not seem to be present as a membrane protein during any phase of erythrocyte
maturation [23]. As such, and at least in anemia conditions, the higher hg and earlier tfr1
expressions in the spleen may indicate that it is the first erythropoietic organ to respond by
increasing erythrocyte production, whereas the head kidney would later take a more unassum-
ing role in maintaining normal erythrocyte levels.
Gene expression in the intestine, the major organ of iron absorption in vertebrates, was also
investigated. Unlike mammals, where the absorption occurs mainly in the duodenal region
[46], in fish absorption seems to occur mainly in the posterior regions of the intestine [47–49],
hence the focus on this region. The increased expressions of slc11a2a, the most likely candidate
for non-heme iron uptake in the posterior intestine of sea bass [49], and of the iron exporter
fpn, together with the decrease in fth, suggest an increase in dietary iron absorption and release
from storage from the intestinal enterocytes, either to be forwarded to the head kidney and
spleen for erythropoiesis, or to the liver to replenish the iron stores. Interestingly, in conditions
of severe anemia, we also observed a decrease of bmp6 expression. Taking into account the con-
stitutive levels of bmp6, highest in the liver but also considerably high in the posterior intestine,
we cannot discard the possibility that, at least in teleost fish, although the liver seems to be the
major regulator of bmp6 levels, there might be some contribution by the intestinal cells when
the anemia is more severe, further fueling the controversy regarding the cellular origin of
BMP6 [34, 35].
Finally, we investigated the effects of sea bass synthetic peptides on the hematological
parameters and liver iron content. A single Hamp1 mature peptide has been described for sea
bass, whereas several Hamp2 mature peptides are expected to exist [22]. As such, we tested the
effects of both Hamp1 and two different Hamp2 mature peptides. Only the administration of
Hamp1 was found to have any effect on the evaluated parameters, leading to significant
decreases in red blood cell numbers, hematocrit, circulating serum iron and transferrin satura-
tion, indicating an early onset of anemia. This suggests that Hamp1 may be causing iron reten-
tion in the liver hepatocytes [16], which could be corroborated by the increased levels of iron in
the liver, and most likely also in the reticuloendothelial macrophages in the hematopoietic
organs [15], leading to an impaired red blood cell production, and in the intestinal enterocytes
[15], limiting iron release and absorption, by blocking its target, the sole known iron exporter
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ferroportin [50]. This is consistent with previous observations showing that in sea bass,
Hamp1 seems to have a major role in the regulation of iron homeostasis, whereas Hamp2 is
almost exclusively involved in the antimicrobial response [22]. Additional experiments will be
required to further clarify the exact physiological role that Hamp1 may exert on the organism.
Conclusions
The mechanisms of response to anemia seem to be well conserved in teleost fish, namely sea
bass, when compared with mammalian models, with different degrees of anemia eliciting dif-
ferent responses. Our results demonstrate that in response to experimental anemia, the liver
assumes the main role on systemic iron metabolism regulation, through the key iron metabo-
lism regulator hepcidin, whereas the spleen and head kidney increase their erythropoietic activ-
ity, and the intestine enhances iron absorption, presumably to provide the organism with the
necessary iron for erythropoiesis. Our study indicates that each hepcidin type plays a diverse
role in response to anemia, with different transcriptional responses and impact on hematologi-
cal parameters and liver iron content.Hamp1 seems to assume a role as the major regulator of
iron homeostasis when enhanced erythropoiesis is required, with a possible secondary role for
hamp2, when confronted with a severe anemia status. Further studies will be required to clarify
the full extent of these roles.
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